首页> 美国卫生研究院文献>Indian Journal of Psychiatry >Sale of medicines by Registered Medical Practitioners at their clinics: Legal and ethical issues
【2h】

Sale of medicines by Registered Medical Practitioners at their clinics: Legal and ethical issues

机译:注册执业医生在诊所出售药品:法律和道德问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In India, manufacturing, storing, transportation, distribution, and dispensing of drugs are licensed and regulated under the drugs and cosmetic act, 1940; Indian Medical Council Act, 1956; the Pharmacy Act, 1948; and the Narcotic Drugs and Psychotropic Substances Act, 1985. Prescribing and dispensing medicines at the same time to their patients by registered medical practitioners (RMPs) is a well-known practice in all systems of medicine across the country. Further, the kind of branded medicines a patient gets from the clinics will come wrapped in a huge profit margin for RMPs, and this has been an alternative source of income to them. Dispensing and selling of medicines by RMPs at their clinics to their patients may represent a significant potential conflict of interest with the medical ethical principles, namely autonomy, beneficence, and non-maleficence and it raises various ethical and legal challenges. This article focuses on the ethical and legal issues of this practice and emphasizes the need for a proactive and dynamic approach to meet the rising demand for quality healthcare in India.
机译:在印度,根据1940年《药品和化妆品法》,药品的制造,储存,运输,分配和分发均受许可和监管。 1956年《印度医学委员会法》; 1948年《药品法》; 1985年《麻醉药品和精神药物法》。在全国所有药物系统中,由注册执业医师(RMP)同时向患者开药和配药是众所周知的做法。此外,患者从诊所获得的品牌药品将被包装在RMP的巨大利润中,这已成为RMP的另一种收入来源。 RMP在其诊所向患者分发和销售药品可能代表着与医学伦理原则(即自治,善意和非恶意)的重大潜在利益冲突,这带来了各种伦理和法律挑战。本文重点介绍这种做法的道德和法律问题,并强调需要一种积极主动的方法来满足印度对高质量医疗保健不断增长的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号